Time and time again, our networking within national and international working groups and research groups delivers new findings on hemato-oncological diseases in childhood and adolescence and guarantees optimal use of state-of-the-art therapy concepts while improving the prospects for a cure, advancing treatment options and limiting therapy-induced side effects and late effects.
The Division of Paediatric and Adolescent Haematology/Oncology has its own research lab, which conducts ongoing research projects in addition to a broad range of complementary diagnostic services.
The networking of the division within the framework of international therapy optimization studies and registries as well as our function as a national study coordination center for several malignant CNS tumors (medulloblastomas, high malignant gliomas, ependymomas) and retinoblastomas also mean a considerable organizational-administrative effort. The Division of Paediatric Haematology/Oncology employs three research and study assistants and one project manager for studies funded by the Steirische Kinderkrebshilfe (Styrian childhood cancer organization).
